https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-16 / Cell Death Differ. 2009 Apr;16(4):638-47
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-16 / Cell Death Differ. 2009 Apr;16(4):638-472009-01-16 00:00:002019-02-15 09:17:36Regulation of heat-induced apoptosis by Mcl-1 degradation and its inhibition by Hsp70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-15 / Cancer 2009 Jan;115(2):311-23
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-15 / Cancer 2009 Jan;115(2):311-232009-01-15 00:00:002019-02-15 09:17:38Hyperthermia-treated mesenchymal stem cells exert antitumor effects on human carcinoma cell line
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-13 / Cancer Immunol. Immunother. 2009 Aug;58(8):1257-64
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-13 / Cancer Immunol. Immunother. 2009 Aug;58(8):1257-642009-01-13 00:00:002019-02-15 08:44:20Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-12 / J. Clin. Oncol. 2009 Feb;27(6):945-52
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-12 / J. Clin. Oncol. 2009 Feb;27(6):945-522009-01-12 00:00:002019-02-15 08:49:55Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-09 / Immunol. Lett. 2009 Jan;122(1):58-67
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-09 / Immunol. Lett. 2009 Jan;122(1):58-672009-01-09 00:00:002019-02-15 08:44:28Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Semin. Hematol. 2009 Jan;46(1):76-88
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Semin. Hematol. 2009 Jan;46(1):76-882009-01-01 00:00:002019-02-15 08:32:29New therapeutic strategies in acute lymphoblastic leukemia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Handb Exp Pharmacol 2009;(188):319-48
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Handb Exp Pharmacol 2009;(188):319-482009-01-01 00:00:002019-02-15 08:32:29Dendritic cell-based immunotherapy in myeloid leukaemia: translating fundamental mechanisms into clinical applications
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Expert Rev Vaccines 2009 Jan;8(1):25-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Expert Rev Vaccines 2009 Jan;8(1):25-82009-01-01 00:00:002019-02-15 08:38:02Recent advances in cancer immunotherapy with an emphasis on vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Expert Rev Vaccines 2009 Jan;8(1):51-66
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Expert Rev Vaccines 2009 Jan;8(1):51-662009-01-01 00:00:002021-11-15 17:02:36Randomized clinical studies of anti-tumor vaccination: state of the art in 2008
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Drugs 2009;69(3):241-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Drugs 2009;69(3):241-92009-01-01 00:00:002019-02-15 08:46:48Tumour vaccine approaches for CNS malignancies: progress to date
